US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
US4954617A
(en)
|
1986-07-07 |
1990-09-04 |
Trustees Of Dartmouth College |
Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・2・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
US5013653A
(en)
|
1987-03-20 |
1991-05-07 |
Creative Biomolecules, Inc. |
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
WO1988009344A1
(fr)
|
1987-05-21 |
1988-12-01 |
Creative Biomolecules, Inc. |
Proteines mutifonctionnelles a cible predeterminee
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
GB9019812D0
(en)
|
1990-09-11 |
1990-10-24 |
Scotgen Ltd |
Novel antibodies for treatment and prevention of infection in animals and man
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
GB9223377D0
(en)
|
1992-11-04 |
1992-12-23 |
Medarex Inc |
Humanized antibodies to fc receptors for immunoglobulin on human mononuclear phagocytes
|
US5589579A
(en)
|
1994-07-19 |
1996-12-31 |
Cytoclonal Pharmaceutics, Inc. |
Gene sequence and probe for a marker of non-small cell lung carinoma
|
WO2000075316A1
(fr)
|
1999-06-02 |
2000-12-14 |
Genentech, Inc. |
Procedes et compositions pour l'inhibition de la croissance de cellules neoplastiques
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US5677139A
(en)
|
1995-04-21 |
1997-10-14 |
President And Fellows Of Harvard College |
In vitro differentiation of CD34+ progenitor cells into T lymphocytes
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
KR19990077146A
(ko)
|
1996-01-11 |
1999-10-25 |
길리스 스티브 |
유방암의 치료 및 진단용 조성물 및 방법
|
WO2001049715A2
(fr)
|
2000-01-06 |
2001-07-12 |
Genentech, Inc. |
Methodes et compositions permettant d'inhiber la croissance cellulaire neoplasique
|
WO2000075327A1
(fr)
|
1999-06-02 |
2000-12-14 |
Genentech, Inc. |
Methodes et compositions d'inhibition de croissance cellulaire neoplasique
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
US7368531B2
(en)
|
1997-03-07 |
2008-05-06 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
US20070224663A1
(en)
|
1997-03-07 |
2007-09-27 |
Human Genome Sciences, Inc. |
Human Secreted Proteins
|
US7411051B2
(en)
|
1997-03-07 |
2008-08-12 |
Human Genome Sciences, Inc. |
Antibodies to HDPPA04 polypeptide
|
US20020127584A1
(en)
|
1997-09-18 |
2002-09-12 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030073129A1
(en)
|
1998-09-01 |
2003-04-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030022298A1
(en)
|
1997-09-15 |
2003-01-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030166104A1
(en)
|
1997-09-18 |
2003-09-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030027272A1
(en)
|
1997-09-18 |
2003-02-06 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20050196832A1
(en)
|
1997-09-18 |
2005-09-08 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030008352A1
(en)
|
1997-09-18 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030166109A1
(en)
|
1997-09-18 |
2003-09-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7160985B2
(en)
|
1997-10-29 |
2007-01-09 |
Genentech, Inc. |
Pro180 polypeptide
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
US20030040471A1
(en)
|
1998-04-29 |
2003-02-27 |
Watson James D. |
Compositions isolated from skin cells and methods for their use
|
US20030022835A1
(en)
|
1998-04-29 |
2003-01-30 |
Genesis Research And Development Corporation Limited |
Compositions isolated from skin cells and methods for their use
|
JP3428441B2
(ja)
|
1998-05-15 |
2003-07-22 |
エーザイ株式会社 |
タイトジャンクション構成膜蛋白質クローディンファミリー
|
US7351543B2
(en)
|
1998-06-02 |
2008-04-01 |
Genentech, Inc. |
Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma
|
US7319008B2
(en)
|
1998-06-02 |
2008-01-15 |
Genentech, Inc. |
Nucleic acid underexpressed in melanoma
|
EP1084142A4
(fr)
|
1998-06-11 |
2005-01-19 |
Smithkline Beecham Corp |
Recepteur de gpr35a
|
EP1104486A4
(fr)
|
1998-08-04 |
2002-07-17 |
Diadexus Llc |
Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
|
US20030166132A1
(en)
|
1998-08-26 |
2003-09-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7038019B2
(en)
|
1998-09-01 |
2006-05-02 |
Genentech, Inc. |
Antibodies to PRO1410
|
CA2339043A1
(fr)
|
1998-09-01 |
2000-03-09 |
Genentech, Inc. |
Nouveaux pro-polypeptides et sequences correspondantes
|
US7071304B2
(en)
|
1998-09-01 |
2006-07-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030082626A1
(en)
|
1998-09-01 |
2003-05-01 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20050181478A1
(en)
|
1998-09-01 |
2005-08-18 |
Baker Kevin P. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU5922999A
(en)
|
1998-09-16 |
2000-04-03 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1112364A2
(fr)
|
1998-09-16 |
2001-07-04 |
ZymoGenetics, Inc. |
Polypeptide stomacal zsig28
|
WO2000020447A2
(fr)
*
|
1998-10-06 |
2000-04-13 |
Curagen Corporation |
Nouvelles proteines secretees, et polynucleotides les codant
|
US7399834B2
(en)
|
1998-10-07 |
2008-07-15 |
Genentech, Inc. |
Anti-PRO1558 antibodies
|
EP1080209A2
(fr)
|
1998-10-21 |
2001-03-07 |
Arch Development Corporation |
Procede de traitement des diabetes de type 2
|
US20030190669A1
(en)
|
1998-12-30 |
2003-10-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7026449B2
(en)
|
1999-01-05 |
2006-04-11 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1263948A2
(fr)
|
1999-03-08 |
2002-12-11 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
|
US7507404B2
(en)
|
1999-03-08 |
2009-03-24 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1159419A1
(fr)
|
1999-03-08 |
2001-12-05 |
Genentech, Inc. |
Activation et inhibition de l'angiogenese et de la cardiovascularisation
|
US20040010134A1
(en)
|
2000-04-12 |
2004-01-15 |
Rosen Craig A. |
Albumin fusion proteins
|
NZ527292A
(en)
|
1999-03-23 |
2005-03-24 |
Genentech Inc |
Secreted and transmembrane polypeptides PRO1484 and nucleic acids encoding the same, with homology to an adipocyte complement-related protein
|
WO2000058473A2
(fr)
|
1999-03-31 |
2000-10-05 |
Curagen Corporation |
Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
|
US20080286821A1
(en)
|
1999-05-14 |
2008-11-20 |
Eaton Dan L |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1210418B1
(fr)
|
1999-06-02 |
2010-08-18 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires ainsi que les acides nucleiques codant pour ceux-ci
|
DK1185648T3
(da)
|
1999-06-02 |
2007-07-30 |
Genentech Inc |
Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst
|
EP1208195A2
(fr)
|
1999-06-15 |
2002-05-29 |
Genentech Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
|
AU2883700A
(en)
|
1999-06-23 |
2001-01-09 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU2883900A
(en)
|
1999-07-07 |
2001-01-30 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU7573000A
(en)
|
1999-09-01 |
2001-03-26 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU1205901A
(en)
|
1999-10-14 |
2001-04-23 |
Board Of Trustees Of The University Of Arkansas, The |
Tumor antigen derived gene-16 (tadg-16): a novel extracellular serine protease and uses thereof
|
EP1250426A2
(fr)
|
1999-12-01 |
2002-10-23 |
Genentech Inc. |
Polypeptides transmembranaires et secretes et les acides nucleiques codant ceux-ci
|
US6380362B1
(en)
|
1999-12-23 |
2002-04-30 |
Genesis Research & Development Corporation Ltd. |
Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
|
WO2001055326A2
(fr)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Acides nucleiques, proteines et anticorps
|
WO2001055355A1
(fr)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Acides nucleiques, proteines et anticorps
|
CA2396719A1
(fr)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
22 proteines humaines secretees
|
US20040018969A1
(en)
|
2000-01-31 |
2004-01-29 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
EP1261711A2
(fr)
|
2000-02-22 |
2002-12-04 |
Corixa Corporation |
Compositions et methodes destinees au diagnostic et a la therapie du mesotheliome malin
|
AU6802801A
(en)
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030165831A1
(en)
|
2000-03-21 |
2003-09-04 |
John Lee |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
AU2001260847A1
(en)
|
2000-05-24 |
2001-12-03 |
Genesis Research And Development Corporation Limited |
Compositions isolated from skin cells and methods for their use
|
AU2001271589A1
(en)
|
2000-06-30 |
2002-01-14 |
Zymogenetics Inc. |
Mammalian secreted proteins
|
CA2634294A1
(fr)
|
2000-08-03 |
2002-02-14 |
Therapeutic Human Polyclonals, Inc. |
Production d'anticorps humanises dans des animaux transgeniques
|
JP2004512029A
(ja)
|
2000-08-16 |
2004-04-22 |
カイロン コーポレイション |
ヒト遺伝子および遺伝子発現産物
|
US7442765B2
(en)
|
2000-08-24 |
2008-10-28 |
Genentech, Inc. |
Secreted transmembrane polypeptides and nucleic acids encoding the same
|
AU2001286810A1
(en)
|
2000-08-28 |
2002-03-13 |
Diadexus, Inc. |
Compositions and methods relating to lung specific genes
|
EP2298789B1
(fr)
|
2000-09-08 |
2012-03-14 |
Schering Corporation |
Gènes mammaliens, reactifs et méthodes associés
|
AU2001292728A1
(en)
|
2000-09-18 |
2002-03-26 |
Thomas Jefferson University |
Compositions and methods for identifying and targeting stomach and esophageal cancer cells
|
ES2295228T3
(es)
|
2000-11-30 |
2008-04-16 |
Medarex, Inc. |
Roedores transcromosomicos transgenicos para la preparacion de anticuerpos humanos.
|
WO2002061087A2
(fr)
|
2000-12-19 |
2002-08-08 |
Lifespan Biosciences, Inc. |
Peptides antigeniques destines a des recepteurs couples a la proteine g (gpcr), anticorps s'y rapportant, et systeme d'identification desdits peptides antigeniques
|
WO2002068579A2
(fr)
|
2001-01-10 |
2002-09-06 |
Pe Corporation (Ny) |
Kits tels que des dosages d'acides nucleiques comprenant une majorite d'exons ou de transcrits humains, destines a detecter l'expression et pouvant avoir d'autres applications
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
WO2002066682A2
(fr)
|
2001-01-29 |
2002-08-29 |
Phase-1 Molecular Toxicology, Inc. |
Us0204917genes de rats en rapport avec la toxicologie, et leurs utilisations
|
WO2002068600A2
(fr)
|
2001-02-26 |
2002-09-06 |
Arena Pharmaceuticals, Inc. |
Versions endogene et non endogenes de recepteurs humains couples aux proteines g
|
US20030152939A1
(en)
|
2001-04-09 |
2003-08-14 |
Glennda Smithson |
Novel secreted proteins and polynucleotides encoding them
|
US20060084794A1
(en)
|
2001-04-12 |
2006-04-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
JP2003000249A
(ja)
|
2001-05-10 |
2003-01-07 |
Daiichi Fine Chemical Co Ltd |
クローディンによるMT−MMPsを介したproMMP−2活性化
|
AU2002330714A1
(en)
|
2001-05-30 |
2003-01-02 |
Biomedical Center |
In silico screening for phenotype-associated expressed sequences
|
US20030148264A1
(en)
|
2001-07-06 |
2003-08-07 |
Genentech, Inc. |
Phage displayed PDZ domain ligands
|
EP1443951A4
(fr)
|
2001-08-03 |
2006-05-03 |
Arbor Vita Corp |
Interactions moleculaires dans les cellules
|
US20050282743A1
(en)
*
|
2001-08-03 |
2005-12-22 |
Arbor Vita Corporation |
Molecular interactions in cells
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
CA2379661A1
(fr)
|
2002-03-28 |
2003-09-28 |
Kursad Turksen |
Systeme d'administration paracellulaire de medicament
|
AU2003240495A1
(en)
|
2002-06-04 |
2003-12-19 |
Incyte Corporation |
Diagnostics markers for lung cancer
|
WO2004029207A2
(fr)
|
2002-09-27 |
2004-04-08 |
Xencor Inc. |
Variants fc optimises et methodes destinees a leur generation
|
WO2004029629A1
(fr)
*
|
2002-09-27 |
2004-04-08 |
Janssen Pharmaceutica N.V. |
Anticorps monoclonaux beta-amyloide n-11 tronques, compositions, methodes et utilisations
|
PL216630B1
(pl)
|
2002-10-17 |
2014-04-30 |
Genmab As |
Izolowane ludzkie przeciwciało monoklonalne wiążące ludzki CD20, związane z tym przeciwciałem transfektoma, komórka gospodarza, transgeniczne zwierzę lub roślina, kompozycja, immunokoniugat, cząsteczka bispecyficzna, wektor ekspresyjny, kompozycja farmaceutyczna, zastosowanie medyczne, zestaw oraz przeciwciało antyidiotypowe i jego zastosowanie
|
EP1578365A4
(fr)
|
2002-11-14 |
2009-09-23 |
Arbor Vita Corp |
Interactions moleculaires dans des neurones
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
EP1430902A1
(fr)
|
2002-12-20 |
2004-06-23 |
Mondobiotech Laboratories Anstalt |
Composition pharmaceutique comprenant l'interferon gamma avec diagnostic moléculaire pour un meilleur traitment de l'asthme
|
US7355008B2
(en)
|
2003-01-09 |
2008-04-08 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
WO2004063355A2
(fr)
|
2003-01-10 |
2004-07-29 |
Protein Design Labs, Inc. |
Nouveaux procedes de diagnostic d'un cancer metastatique, compositions et procedes de depister des modulateurs du cancer metastatique
|
KR20060031809A
(ko)
|
2003-06-09 |
2006-04-13 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
암 치료 및 진단용 조성물 및 방법
|
JP2007507243A
(ja)
|
2003-10-03 |
2007-03-29 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
遺伝子発現プロファイルおよび使用方法
|
DE10354601B3
(de)
|
2003-11-21 |
2005-06-23 |
Chiropro Gmbh |
Gelenkprothese für Fingerglieder
|
WO2005052182A2
(fr)
|
2003-11-26 |
2005-06-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Procede d'analyse de contenu de proteine a membrane plasmique de cellules
|
US20080119412A1
(en)
|
2003-12-23 |
2008-05-22 |
Nono Inc. |
Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins
|
WO2005076939A2
(fr)
|
2004-02-09 |
2005-08-25 |
University Of Kentucky Research Foundation |
Test et procede de diagnostic et de traitement de la maladie d'alzheimer
|
WO2005082398A2
(fr)
|
2004-02-26 |
2005-09-09 |
Ohio University |
Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de façon differentielle dans les cellules musculaires
|
US20050255041A1
(en)
|
2004-05-13 |
2005-11-17 |
Arius Research, Inc. |
Cancerous disease modifying antibodies
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
DE602005013670D1
(de)
|
2004-05-21 |
2009-05-14 |
Inst Systems Biology |
Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
|
WO2006023121A1
(fr)
|
2004-07-27 |
2006-03-02 |
Ohio University |
Diagnostic d'hyperinsulinemie et de diabete de type ii et protection contre ceux-ci a base de genes differentiellement exprimes dans le tissu adipeux blanc (13)
|
DE102004042822A1
(de)
|
2004-08-31 |
2006-03-16 |
Technische Universität Dresden |
Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen
|
FR2876705B1
(fr)
|
2004-10-19 |
2008-12-12 |
Biomerieux Sa |
Procede pour le diagnostic d'une intolerance a l'aspirine
|
US20070072175A1
(en)
|
2005-05-13 |
2007-03-29 |
Biogen Idec Ma Inc. |
Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
|
EP1910837B1
(fr)
|
2005-07-01 |
2012-03-14 |
Arbor Vita Corporation |
Methodes et compositions de diagnostic et de traitement de la grippe
|
WO2007021423A2
(fr)
|
2005-08-15 |
2007-02-22 |
Genentech, Inc. |
Disruptions et compositions geniques et procedes associes
|
EP2182057A1
(fr)
*
|
2005-08-31 |
2010-05-05 |
Cell Signaling Technology, Inc. |
Anticorps contre tyrosine phosphorylée pour la détection de la phosphorylation de protéines dans des voies signalant un carcinome
|
DK2402758T3
(da)
|
2005-09-19 |
2014-11-03 |
Janssen Diagnostics Llc |
Fremgangsmåder og anvendelser til identificering af oprindelsen af et karcinom med ukendt primær oprindelse
|
WO2007047796A2
(fr)
|
2005-10-17 |
2007-04-26 |
Institute For Systems Biology |
Glycoproteines derivees de tissus et du serum et leurs methodes d'utilisation
|
EP1790664A1
(fr)
*
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
|
ES2582652T3
(es)
*
|
2006-02-10 |
2016-09-14 |
Genentech, Inc. |
Anticuerpos anti-FGF19 y métodos de uso de los mismos
|
WO2007115045A2
(fr)
|
2006-03-29 |
2007-10-11 |
Genentech, Inc. |
Diagnostics et traitements de tumeurs
|
WO2008013948A2
(fr)
|
2006-07-27 |
2008-01-31 |
Cell Signaling Technology, Inc. |
Sites de phosphorylation de tyrosines
|
WO2008021290A2
(fr)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Protéines spécifiques d'organes et procédés d'utilisation
|
WO2008021115A2
(fr)
|
2006-08-14 |
2008-02-21 |
The Brigham And Women's Hospital, Inc. |
Tests de diagnostic utilisant des rapports d'expression génique
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
MX2009002936A
(es)
|
2006-09-19 |
2009-04-01 |
Novartis Ag |
Biomarcadores de la modulacion de objetivo, eficacia, diagnostico, y/o pronostico para los inhibidores de raf.
|
EP2087110A2
(fr)
|
2006-10-11 |
2009-08-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Cibles de la grippe
|
WO2008073303A2
(fr)
|
2006-12-07 |
2008-06-19 |
Switchgear Genomics |
Éléments de régulation transcriptionnelle de voies biologiques, outils, et procédés
|
AU2007333106A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
miR-20 regulated genes and pathways as targets for therapeutic intervention
|
CA2677118A1
(fr)
|
2007-02-01 |
2008-08-07 |
Veridex, Llc |
Procedes et substances permettant d'identifier l'origine d'un carcinome d'origine principale inconnue
|
EP2145902A3
(fr)
|
2007-04-19 |
2010-09-29 |
Peter Hornbeck |
Sites de phosphorylation à tyrosine et anticorps spécifiques
|
EP1997832A1
(fr)
|
2007-05-29 |
2008-12-03 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux contre la claudine-18 pour le traitement contre le cancer
|
JP2010529966A
(ja)
|
2007-06-08 |
2010-09-02 |
アシュラジェン インコーポレイテッド |
治療的介入の標的としてmiR−34によって調節される遺伝子および経路
|
WO2009015050A2
(fr)
|
2007-07-20 |
2009-01-29 |
The Gov. Of The U.S.A. As Represented By The Secretary Of The Department Of Health & Human Services |
Profil d'expression génique pour prédire la survie d'une patiente atteinte d'un cancer des ovaires
|
WO2009035497A2
(fr)
|
2007-08-08 |
2009-03-19 |
Savidge Tor C |
Modifications de cystéine associées à une maladie et leur utilisation
|
EP2036987A1
(fr)
|
2007-09-17 |
2009-03-18 |
Siemens Healthcare Diagnostics GmbH |
Marqueurs moléculaires pour le contenu de cellules de tumeurs dans des échantillons de tissus
|
EP2209894B1
(fr)
|
2007-10-12 |
2015-06-03 |
The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin |
Procédé pour l'ouverture de jonctions serrées
|
US8563515B2
(en)
|
2007-11-19 |
2013-10-22 |
The Regents Of The University Of Colorado, A Body Corporate |
Tight junction protein modulators and uses thereof
|
KR20110018930A
(ko)
|
2008-06-02 |
2011-02-24 |
엔에스에이비피 파운데이션, 인크. |
암 치료에서 예후적 및 예견적 마커의 확인 및 용도
|
WO2009155609A1
(fr)
|
2008-06-20 |
2009-12-23 |
Oklahoma Medical Research Foundation |
PEPTIDES IMMUNOGÈNES DE LA MÉMAPSINE 2 β-SECRÉTASE ET PROCÉDÉS D'UTILISATION
|
US20110190380A1
(en)
|
2008-10-23 |
2011-08-04 |
Elena Feinstein |
Methods for delivery of sirna to bone marrow cells and uses thereof
|
CN101381524A
(zh)
|
2008-10-24 |
2009-03-11 |
南开大学 |
单层氧化石墨与水溶性高分子增强复合材料
|
US20110286916A1
(en)
|
2008-11-20 |
2011-11-24 |
Jose Miguel Aste-Amezaga |
Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
|
GB0904957D0
(en)
|
2009-03-23 |
2009-05-06 |
Univ Erasmus Medical Ct |
Tumour gene profile
|
WO2010120526A2
(fr)
|
2009-03-31 |
2010-10-21 |
Emory University |
Procédés et systèmes destinés au dépistage et au diagnostic de la méthylation de l'adn associée aux troubles du spectre autistique
|
CN101584860A
(zh)
*
|
2009-04-27 |
2009-11-25 |
西安杰诺瓦生物科技有限公司 |
重组人Claudin18.2肿瘤疫苗及其制备方法
|
JP2013505730A
(ja)
|
2009-10-01 |
2013-02-21 |
チップディーエックス エルエルシー |
患者を分類するためのシステムおよび方法
|
AU2010326066A1
(en)
|
2009-12-01 |
2012-06-21 |
Compendia Bioscience, Inc. |
Classification of cancers
|
EP2366709A1
(fr)
|
2010-03-16 |
2011-09-21 |
BioNTech AG |
Vaccination anti-tumeur impliquant une réponse immunitaire humorale contre les protéines endogènes
|
CA2786940C
(fr)
*
|
2010-03-16 |
2019-09-24 |
Biontech Ag |
Vaccin contre une tumeur impliquant une reponse immunitaire a mediation humorale et proteines associees, y compris l'ensemble ou une portion de la proteine antigene du noyau du virus b de l'hepatite et un epitope de claudin 18.2
|
US8945847B2
(en)
|
2010-05-24 |
2015-02-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for ascertaining biosafety of an agent
|
JP2013529089A
(ja)
|
2010-06-07 |
2013-07-18 |
エフ.ホフマン−ラ ロシュ アーゲー |
インターロイキン−6受容体を阻害するモノクローナル抗体による薬剤治療に対する応答を予測するための遺伝子発現マーカー
|
US8454385B2
(en)
|
2010-06-22 |
2013-06-04 |
John Mezzalingua Associates, LLC |
Coaxial cable connector with strain relief clamp
|
WO2012070014A2
(fr)
|
2010-11-26 |
2012-05-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Identification de nouveaux marqueurs de surface cellulaire pour des cellules progénitrices pancréatiques et des cellules endodermiques définies
|
WO2012096272A1
(fr)
|
2011-01-12 |
2012-07-19 |
森永乳業株式会社 |
Procédé de criblage pour des aliments pour animaux qui permettent la production de lait ayant une activité immunomodulatrice
|
DE102011005235B4
(de)
|
2011-03-08 |
2017-05-24 |
Sirs-Lab Gmbh |
Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten
|
EP2834259A4
(fr)
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
Polynucléotides modifiés
|
WO2013167153A1
(fr)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Anticorps utiles dans le diagnostic du cancer
|
WO2013174403A1
(fr)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
WO2013174404A1
(fr)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
WO2014025199A2
(fr)
|
2012-08-09 |
2014-02-13 |
주식회사 한독 |
Mutant de superantigène issu d'entérotoxine staphylococcique, protéine de fusion dans laquelle des polypeptides spécifiques d'une cible sont connectés au mutant et leur utilisation
|
WO2014025198A2
(fr)
|
2012-08-09 |
2014-02-13 |
주식회사 한독 |
Mutant de lfa3, protéine de fusion dans laquelle des polypeptides spécifiques d'une cible sont connectés au mutant ou à la région de liaison à cd2 de lfa3, et leur utilisation
|
EP2888391A4
(fr)
|
2012-08-24 |
2016-09-14 |
Univ Utah Res Found |
Compositions et méthodes se rapportant à des biomarqueurs sanguins du cancer du sein
|
US20140073524A1
(en)
|
2012-09-07 |
2014-03-13 |
Institute For Systems Biology |
Markers and methods for detecting posttraumatic stress disorder (ptsd)
|
US9856532B2
(en)
|
2012-09-07 |
2018-01-02 |
Institute For Systems Biology |
Markers and methods for detecting posttraumatic stress disorder (PTSD)
|